Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
The amount of force generated by MUSCLE CONTRACTION. Muscle strength can be measured during isometric, isotonic, or isokinetic contraction, either manually or using a device such as a MUSCLE STRENGTH DYNAMOMETER.
A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
Force exerted when gripping or grasping.
A housing and community arrangement that maximizes independence and self-determination.
Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.
The relative amounts of various components in the body, such as percentage of body fat.
Disorders characterized by an abnormal reduction in muscle volume due to a decrease in the size or number of muscle fibers. Atrophy may result from diseases intrinsic to muscle tissue (e.g., MUSCULAR DYSTROPHY) or secondary to PERIPHERAL NERVOUS SYSTEM DISEASES that impair innervation to muscle tissue (e.g., MUSCULAR ATROPHY, SPINAL).
General ill health, malnutrition, and weight loss, usually associated with chronic disease.
Nutritional physiology of adults aged 65 years of age and older.
Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism.
Evaluation of the level of physical, physiological, or mental functioning in the older population group.
A noninvasive method for assessing BODY COMPOSITION. It is based on the differential absorption of X-RAYS (or GAMMA RAYS) by different tissues such as bone, fat and other soft tissues. The source of (X-ray or gamma-ray) photon beam is generated either from radioisotopes such as GADOLINIUM 153, IODINE 125, or Americanium 241 which emit GAMMA RAYS in the appropriate range; or from an X-ray tube which produces X-RAYS in the desired range. It is primarily used for quantitating BONE MINERAL CONTENT, especially for the diagnosis of OSTEOPOROSIS, and also in measuring BONE MINERALIZATION.
Reduction in caloric intake without reduction in adequate nutrition. In experimental animals, caloric restriction has been shown to extend lifespan and enhance other physiological variables.
Difficulty in walking from place to place.
Changes in the organism associated with senescence, occurring at an accelerated rate.

Longitudinal analysis of early stage sarcopenia in aging rhesus monkeys. (1/225)

 (+info)

Age-related changes of cell death pathways in rat extraocular muscle. (2/225)

 (+info)

Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. (3/225)

 (+info)

Effects of aging on human skeletal muscle after immobilization and retraining. (4/225)

 (+info)

Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. (5/225)

 (+info)

Sarcopenia: etiology, clinical consequences, intervention, and assessment. (6/225)

 (+info)

Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression. (7/225)

 (+info)

Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. (8/225)

 (+info)

Sarcopenia is a medical term that refers to the age-related decline in muscle mass, strength, and function. It's a natural process that occurs as we get older, but it can also be accelerated by various factors such as sedentary lifestyle, poor nutrition, and chronic diseases. Sarcopenia can lead to decreased mobility, weakness, frailty, and increased risk of falls and fractures in older adults. It's important to note that sarcopenia is different from cachexia, which is a muscle wasting condition associated with chronic illnesses such as cancer, HIV/AIDS, and heart failure.

Muscular atrophy is a condition characterized by a decrease in the size and mass of muscles due to lack of use, disease, or injury. This occurs when there is a disruption in the balance between muscle protein synthesis and degradation, leading to a net loss of muscle proteins. There are two main types of muscular atrophy:

1. Disuse atrophy: This type of atrophy occurs when muscles are not used or are immobilized for an extended period, such as after an injury, surgery, or prolonged bed rest. In this case, the nerves that control the muscles may still be functioning properly, but the muscles themselves waste away due to lack of use.
2. Neurogenic atrophy: This type of atrophy is caused by damage to the nerves that supply the muscles, leading to muscle weakness and wasting. Conditions such as amyotrophic lateral sclerosis (ALS), spinal cord injuries, and peripheral neuropathies can cause neurogenic atrophy.

In both cases, the affected muscles may become weak, shrink in size, and lose their tone and mass. Treatment for muscular atrophy depends on the underlying cause and may include physical therapy, exercise, and medication to manage symptoms and improve muscle strength and function.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

Muscle strength, in a medical context, refers to the amount of force a muscle or group of muscles can produce during contraction. It is the maximum amount of force that a muscle can generate through its full range of motion and is often measured in units of force such as pounds or newtons. Muscle strength is an important component of physical function and mobility, and it can be assessed through various tests, including manual muscle testing, dynamometry, and isokinetic testing. Factors that can affect muscle strength include age, sex, body composition, injury, disease, and physical activity level.

Muscle weakness is a condition in which muscles cannot develop the expected level of physical force or power. This results in reduced muscle function and can be caused by various factors, including nerve damage, muscle diseases, or hormonal imbalances. Muscle weakness may manifest as difficulty lifting objects, maintaining posture, or performing daily activities. It is essential to consult a healthcare professional for proper diagnosis and treatment of muscle weakness.

Hand strength refers to the measure of force or power that an individual can generate using the muscles of the hand and forearm. It is often assessed through various tests, such as grip strength dynamometry, which measures the maximum force exerted by the hand when squeezing a device called a handgrip dynanometer. Hand strength is important for performing daily activities, maintaining independence, and can be indicative of overall health and well-being. Reduced hand strength may be associated with conditions such as neuromuscular disorders, arthritis, or injuries.

"Independent Living," in the context of healthcare and social services, refers to a living arrangement where individuals with disabilities or chronic conditions are able to live on their own, without the need for constant supervision or assistance from healthcare professionals. This type of living situation promotes self-determination, autonomy, and dignity for the individual.

Independent living does not mean that an individual is completely self-sufficient and does not require any help at all. Rather, it means that they have access to the necessary support services and adaptive equipment that enable them to carry out their daily activities and make choices about their own lives. These supports can include personal care assistance, home health care, meal preparation, transportation, and other services that are tailored to meet the individual's unique needs.

Independent living is often facilitated through community-based services and support programs, such as independent living centers, which provide advocacy, information, and referral services to help individuals with disabilities live independently in their own homes and communities. The goal of independent living is to enable people with disabilities to participate fully in all aspects of society, including employment, education, and community life.

The term "frail elderly" is not a formal medical diagnosis, but rather a general description used to identify older adults who are vulnerable and at increased risk for negative health outcomes. Frailty is a complex syndrome characterized by decreased physiological reserve and resistance to stressors, which results in increased vulnerability to adverse outcomes.

The frail elderly often have multiple chronic conditions, cognitive impairment, functional limitations, social isolation, poor nutritional status, and sensory deficits. These factors contribute to a decline in their physical function, mobility, and overall health, making them more susceptible to falls, disability, hospitalization, institutionalization, and mortality.

There are several tools and criteria used to define frailty, including the Frailty Phenotype model proposed by Fried et al., which identifies frailty based on the presence of three or more of the following five criteria: unintentional weight loss, weakness (measured by grip strength), self-reported exhaustion, slow walking speed, and low physical activity. Another commonly used tool is the Clinical Frailty Scale, which assesses frailty based on a person's level of dependence and coexisting medical conditions.

It is important to note that frailty is not an inevitable part of aging, and interventions aimed at addressing its underlying causes can help improve outcomes for the frail elderly. These interventions may include exercise programs, nutritional support, medication management, and social engagement.

Body composition refers to the relative proportions of different components that make up a person's body, including fat mass, lean muscle mass, bone mass, and total body water. It is an important measure of health and fitness, as changes in body composition can indicate shifts in overall health status. For example, an increase in fat mass and decrease in lean muscle mass can be indicative of poor nutrition, sedentary behavior, or certain medical conditions.

There are several methods for measuring body composition, including:

1. Bioelectrical impedance analysis (BIA): This method uses low-level electrical currents to estimate body fat percentage based on the conductivity of different tissues.
2. Dual-energy X-ray absorptiometry (DXA): This method uses low-dose X-rays to measure bone density and body composition, including lean muscle mass and fat distribution.
3. Hydrostatic weighing: This method involves submerging a person in water and measuring their weight underwater to estimate body density and fat mass.
4. Air displacement plethysmography (ADP): This method uses air displacement to measure body volume and density, which can be used to estimate body composition.

Understanding body composition can help individuals make informed decisions about their health and fitness goals, as well as provide valuable information for healthcare providers in the management of chronic diseases such as obesity, diabetes, and heart disease.

Atrophic muscular disorders are medical conditions that involve the progressive loss of muscle mass and weakness due to the degeneration of muscle tissue. This process occurs because of a decrease in the size or number of muscle fibers, which can be caused by various factors such as nerve damage, lack of use, or underlying diseases.

There are two main types of atrophic muscular disorders: neurogenic and myopathic. Neurogenic atrophy is caused by damage to the nerves that supply the muscles, leading to muscle weakness and wasting. Examples of conditions that can cause neurogenic atrophy include motor neuron disease, spinal cord injury, and peripheral neuropathy.

Myopathic atrophy, on the other hand, is caused by primary muscle diseases that affect the muscle fibers themselves. Conditions such as muscular dystrophy, metabolic myopathies, and inflammatory myopathies can all lead to myopathic atrophy.

Symptoms of atrophic muscular disorders may include muscle weakness, wasting, cramping, spasms, and difficulty with movement and coordination. Treatment for these conditions depends on the underlying cause and may involve physical therapy, medication, or surgery. In some cases, the damage to the muscles may be irreversible, and the goal of treatment is to manage symptoms and maintain function as much as possible.

Cachexia is a complex metabolic disorder characterized by severe weight loss, muscle wasting, and weakness. It is often associated with chronic diseases such as cancer, HIV/AIDS, heart failure, kidney disease, and chronic obstructive pulmonary disease (COPD). Cachexia differs from simple malnutrition or starvation in that it involves a significant loss of muscle mass and an imbalance in energy metabolism, even when adequate calories are consumed.

The hallmark features of cachexia include:

1. Weight loss: Unintentional loss of more than 5% of body weight over 12 months or less, or more than 2% in individuals already underweight.
2. Muscle wasting: Reduction in skeletal muscle mass and strength, leading to weakness and functional impairment.
3. Fatigue and anorexia: Decreased appetite and reduced food intake due to various factors such as inflammation, hormonal imbalances, and psychological distress.
4. Inflammation: Elevated levels of pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) that contribute to metabolic dysregulation and muscle wasting.
5. Insulin resistance: Impaired glucose uptake and utilization by cells, leading to increased blood glucose levels and altered energy metabolism.
6. Altered protein metabolism: Increased protein breakdown and decreased protein synthesis in skeletal muscles, contributing to muscle wasting.
7. Altered lipid metabolism: Increased lipolysis (breakdown of fat) and impaired lipogenesis (formation of fat), leading to loss of adipose tissue and altered energy storage.

Cachexia significantly impacts patients' quality of life, treatment outcomes, and overall survival. Currently, there is no single effective treatment for cachexia, and management typically involves addressing the underlying disease, nutritional support, exercise interventions, and pharmacological therapies to target specific aspects of the metabolic dysregulation associated with this condition.

I cannot provide a medical definition for the term "Elder Nutritional Physiological Phenomena" as it is not a widely recognized or established term in the field of medicine or nutrition. It seems to be a very specific and narrow term that may refer to certain age-related changes in nutritional status and physiological functions among older adults. However, I would recommend consulting with a healthcare professional or geriatric specialist for a more accurate and detailed explanation based on the context and specific phenomena being referred to.

Muscular diseases, also known as myopathies, refer to a group of conditions that affect the functionality and health of muscle tissue. These diseases can be inherited or acquired and may result from inflammation, infection, injury, or degenerative processes. They can cause symptoms such as weakness, stiffness, cramping, spasms, wasting, and loss of muscle function.

Examples of muscular diseases include:

1. Duchenne Muscular Dystrophy (DMD): A genetic disorder that results in progressive muscle weakness and degeneration due to a lack of dystrophin protein.
2. Myasthenia Gravis: An autoimmune disease that causes muscle weakness and fatigue, typically affecting the eyes and face, throat, and limbs.
3. Inclusion Body Myositis (IBM): A progressive muscle disorder characterized by muscle inflammation and wasting, typically affecting older adults.
4. Polymyositis: An inflammatory myopathy that causes muscle weakness and inflammation throughout the body.
5. Metabolic Myopathies: A group of inherited disorders that affect muscle metabolism, leading to exercise intolerance, muscle weakness, and other symptoms.
6. Muscular Dystonias: Involuntary muscle contractions and spasms that can cause abnormal postures or movements.

It is important to note that muscular diseases can have a significant impact on an individual's quality of life, mobility, and overall health. Proper diagnosis and treatment are crucial for managing symptoms and improving outcomes.

Wasting syndrome is a condition characterized by significant weight loss and muscle wasting, often accompanied by weakness and decreased appetite. It can be caused by various underlying medical conditions, including HIV/AIDS, cancer, tuberculosis, and other chronic infections or diseases that cause chronic inflammation. In some cases, wasting syndrome can also result from severe malnutrition or gastrointestinal disorders that affect nutrient absorption.

The diagnostic criteria for wasting syndrome vary depending on the underlying cause, but generally, it is defined as a significant loss of body weight (typically more than 10% of body weight) and muscle mass over a period of several months. In addition to weight loss and muscle wasting, individuals with wasting syndrome may also experience fatigue, weakness, decreased immune function, and impaired physical functioning.

Wasting syndrome can have serious consequences on an individual's health and quality of life, and it is often associated with increased morbidity and mortality. Treatment typically involves addressing the underlying cause of the wasting syndrome, as well as providing nutritional support to help individuals regain weight and muscle mass.

A geriatric assessment is a comprehensive, multidimensional evaluation of an older adult's functional ability, mental health, social support, and overall health status. It is used to identify any medical, psychological, or social problems that could affect the person's ability to live independently and safely, and to develop an individualized plan of care to address those issues.

The assessment typically includes a review of the person's medical history, medications, cognitive function, mobility, sensory function, nutrition, continence, and mood. It may also include assessments of the person's social support network, living situation, and financial resources. The goal of the geriatric assessment is to help older adults maintain their independence and quality of life for as long as possible by addressing any issues that could put them at risk for disability or institutionalization.

Photon Absorptiometry is a medical technique used to measure the absorption of photons (light particles) by tissues or materials. In clinical practice, it is often used as a non-invasive method for measuring bone mineral density (BMD). This technique uses a low-energy X-ray beam or gamma ray to penetrate the tissue and then measures the amount of radiation absorbed by the bone. The amount of absorption is related to the density and thickness of the bone, allowing for an assessment of BMD. It can be used to diagnose osteoporosis and monitor treatment response in patients with bone diseases. There are two types of photon absorptiometry: single-photon absorptiometry (SPA) and dual-photon absorptiometry (DPA). SPA uses one energy level, while DPA uses two different energy levels to measure BMD, providing more precise measurements.

Caloric restriction refers to a dietary regimen that involves reducing the total calorie intake while still maintaining adequate nutrition and micronutrient intake. This is often achieved by limiting the consumption of high-calorie, nutrient-poor foods and increasing the intake of nutrient-dense, low-calorie foods such as fruits, vegetables, and lean proteins.

Caloric restriction has been shown to have numerous health benefits, including increased lifespan, improved insulin sensitivity, reduced inflammation, and decreased risk of chronic diseases such as cancer, diabetes, and heart disease. It is important to note that caloric restriction should not be confused with starvation or malnutrition, which can have negative effects on health. Instead, it involves a careful balance of reducing calorie intake while still ensuring adequate nutrition and energy needs are met.

It is recommended that individuals who are considering caloric restriction consult with a healthcare professional or registered dietitian to ensure that they are following a safe and effective plan that meets their individual nutritional needs.

Mobility limitation refers to the partial or complete inability to move or perform functional mobility tasks independently and safely. This condition can affect any part of the body, such as limited joint range of motion, muscle weakness, or neurological impairments, making it difficult for a person to perform activities like walking, standing, transferring, balancing, and reaching. Mobility limitations can be temporary or permanent and vary in severity, significantly impacting a person's quality of life, independence, and overall health.

Premature aging, also known as "accelerated aging" or "early aging," refers to the physiological process in which the body shows signs of aging at an earlier age than typically expected. This can include various symptoms such as wrinkles, graying hair, decreased energy and mobility, cognitive decline, and increased risk of chronic diseases.

The medical definition of premature aging is not well-established, as aging is a complex process influenced by a variety of genetic and environmental factors. However, certain conditions and syndromes are associated with premature aging, such as Hutchinson-Gilford progeria syndrome, Werner syndrome, and Down syndrome.

In general, the signs of premature aging may be caused by a combination of genetic predisposition, lifestyle factors (such as smoking, alcohol consumption, and poor diet), exposure to environmental toxins, and chronic stress. While some aspects of aging are inevitable, maintaining a healthy lifestyle and reducing exposure to harmful factors can help slow down the aging process and improve overall quality of life.

No FAQ available that match "sarcopenia"

No images available that match "sarcopenia"